0 Comment
Madrid (EFE) be as inactive as possible. As reported to Efe by the Spanish Agency for Medicines and Health Products (AEMPS), the supply problems of this drug, an injectable solution in a syringe from the Amdipharm Limited laboratories, will last until May and the cause is due to a increased demand beyond what the company... Read More